Erasca Inc
Change company Symbol lookup
Select an option...
ERAS Erasca Inc
DARE Dare Bioscience Inc
REXR-C Rexford Industrial Realty Inc
AQNA Algonquin Power & Utilities Corp
NAOV Nanovibronix Inc
IOT Samsara Inc
GSIT GSI Technology Inc
GME GameStop Corp
CMBM Cambium Networks Corp
S SentinelOne Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Erasca, Inc. is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. The Company has assembled a wholly owned or controlled RAS/MAPK pathway-focused pipeline including 12 disclosed modality-agnostic programs aligned with its three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. The Company’s pipeline includes five clinical-stage programs, such as a pan-RAF inhibitor, an ERK inhibitor, a SHP2 inhibitor, an EGFR inhibitor, and a central nervous system (CNS)-penetrant KRAS G12C inhibitor, and seven discovery-stage programs targeting other key oncogenic drivers. The Company’s lead product candidate is naporafenib, designed to be a reversible, potent and selective ATP-competitive type 2 pan-RAF kinase inhibitor.

Postmarket

Last Trade
Delayed
$2.92
0.03 (1.04%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.89
Day's Change
0.20 (7.43%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
2.91
Day's Low
2.69
Volume
(Light)
Volume:
421,463

10-day average volume:
614,603
421,463
  • Prev Close
    2.69
  • Today's Open
    2.69
  • Day's Range
    2.69-2.91
  • Avg Vol (10-day)
    614.6K
  • Last (time)
    4:00p ET 06/02/23
  • Last (size)
    100
  • 52-Wk Range
    2.49 - 10.74
    LowHigh
  • (08/16/22 - 04/26/23)
    16.06%
  • 78.4%
  • Market Cap
    435.7M
  • Shares Outstanding
    150.8M
  • -1.87
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 60.68
  • (% of float 05/15/23)
    9.34

Latest News

June 01, 2023
8:01 am ET
Globe Newswire
May 31, 2023
8:00 am ET
Globe Newswire
May 25, 2023
5:00 pm ET
Globe Newswire
May 16, 2023
8:00 am ET
Globe Newswire
May 15, 2023
4:01 pm ET
Globe Newswire
May 02, 2023
8:00 am ET
Globe Newswire
May 01, 2023
8:00 am ET
Globe Newswire
April 26, 2023
5:00 pm ET
Globe Newswire
April 25, 2023
8:00 am ET
Globe Newswire
April 18, 2023
9:00 am ET
Globe Newswire
April 10, 2023
8:00 am ET
Globe Newswire
March 30, 2023
6:46 am ET
MarketWatch
March 23, 2023
4:01 pm ET
Globe Newswire
March 14, 2023
4:31 pm ET
Globe Newswire
December 12, 2022
7:57 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.